Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Outcome of Board Meeting

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in their meeting held on June 27, 2017 have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the company, out of profits of the company for the financial year 2016-2017, subject to the approval of the members in their Annual General Meeting....
27-06-2017
Bigul

Audited Financial Results (Standalone And Consolidated) For The Period Ended On March 31, 2017

 Pursuant to captioned Regulation, please find enclosed herewith a copy of the Audited Financial Results (Standalone and Consolidated) for the period ended on March 31, 2017, as approved by the Board of Directors in their meeting held on even date i.e. June 27, 2017. A copy of the Auditor's Report is also enclosed herewith for your record please. The declaration that audit reports do not contain any modified opinion is also attached.
27-06-2017
Bigul

Annual report for Nectar Lifesciences Ltd. for FY-2017
27-06-2017
Bigul

Nectar Lifesciences: eyes on results

 Nectar Lifesciences' board of directors will meet on Tuesday to consider and approve the audited financial results of the company for financial year 2016-17, financial statements and recommendation...
23-06-2017
Bigul

Notice Of Adjourned Board Meeting To Be Held On June 27, 2017.

 We wish to inform you that the adjourned meeting of the Board of Directors of the company will be held on Tuesday, June 27, 2017 to consider and approve, inter alia amongst items: 1. The Audited Financial Results for the Financial Year 2016-17, Financial Statements of the Company for the Financial Year 2016-17 and matters related thereto....
21-06-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv HUF
26-05-2017
Bigul

Board to consider Final Dividend

 Nectar Lifesciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2017, inter alia, to consider and approve :1. The Audited Financial Results for the Financial Year 2016-17, Financial Statements of the Company for the Financial Year 2016-17 and matters related thereto.2. Recommendation of final dividend to the Members of the Company for Financial Year 2016-17....
23-05-2017
Bigul

Notice Of Board Meeting Meeting To Be Held On May 30, 2017 To Consider Audited Financial Results For The Quarter And Year Ended On March 31, 2017 And To Recommend Final Dividend And Closure Of Trading Window.

 We wish to inform you that a meeting of the Board of Directors of the company will be held on Tuesday 30th May, 2017 to consider and approve, inter alia,: 1. The Audited Financial Results for the Financial Year 2016-17, Financial Statements of the Company for the Financial Year 2016-17 and matters related thereto. 2. Recommendation of final dividend to the Members of the company for Financial Year 2016-17. Further, pursuant to...
23-05-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv Goyal
11-05-2017
Bigul

Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv HUF
24-04-2017
Next Page
Close

Let's Open Free Demat Account